Literature DB >> 3544649

Postoperative pain relief with high-dose epidural buprenorphine: a double-blind study.

R Y Gundersen, R Andersen, G Narverud.   

Abstract

Forty-five patients scheduled for major abdominal or intrathoracic surgery were assigned at random to two different groups. One group received 0.3 mg and the other 0.9 mg of buprenorphine epidurally to abolish postoperative pain. The first dose was given immediately upon arrival in the ICU, irrespective of pain. Subsequent medication was given on demand. The duration of action and side-effects were recorded. Both doses produced excellent and long-lasting pain relief, but no statistically significant difference was found between the groups, with regard to either the duration of action or the occurrence of side-effects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3544649     DOI: 10.1111/j.1399-6576.1986.tb02497.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  5 in total

1.  [Not Available].

Authors:  M Zenz
Journal:  Schmerz       Date:  1987-07       Impact factor: 1.107

2.  Comparison of circulatory and respiratory responses between supplementary epidural buprenorphine and eptazocine administration during and immediately after total intravenous anesthesia.

Authors:  S Aida; H Baba; K Shimoji
Journal:  J Anesth       Date:  1997-06       Impact factor: 2.078

Review 3.  Respiratory depression and spinal opioids.

Authors:  R C Etches; A N Sandler; M D Daley
Journal:  Can J Anaesth       Date:  1989-03       Impact factor: 5.063

4.  Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.

Authors:  Roberto Ciccocioppo; Daina Economidou; Roberto Rimondini; Wolfgang Sommer; Maurizio Massi; Markus Heilig
Journal:  Biol Psychiatry       Date:  2006-03-14       Impact factor: 13.382

5.  Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat.

Authors:  Daina Economidou; Anita C Hansson; Friedbert Weiss; Anton Terasmaa; Wolfgang H Sommer; Andrea Cippitelli; Amalia Fedeli; Rèmi Martin-Fardon; Maurizio Massi; Roberto Ciccocioppo; Markus Heilig
Journal:  Biol Psychiatry       Date:  2008-03-25       Impact factor: 13.382

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.